Mast Cell And Inflammatory Bowel Disease
Copyright ©The Author(s) 2004.
World J Gastroenterol. Feb 1, 2004; 10(3): 337-341
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.337
Table 1 The effects of protease inhibitors on histamine release from human colon mast cells at 15 min incubation period
CompoundConcentrationNet histamine release (%)
ZIGPFM0.001 μmol/mL-0.9 ± 0.8
0.01 μmol/mL0 ± 1.1
0.1 μmol/mL0.8 ± 0.6
1.0 μmol/mL0.2 ± 1.2
TPCK0.08 μmol/mL3.1 ± 2.0
0.8 μmol/mL2.1 ± 1.0
8.0 μmol/mL2.0 ± 1.2
80 μmol/mL0.7 ± 1.1
α1-antitrypsin1.0 μmol/mL0.9 ± 0.5
10 μmol/mL1.1 ± 0.6
30 μmol/mL1.5 ± 0.6
Lactoferrin1.0 μmol/mL-1.0 ± 0.8
10 μmol/mL0.8 ± 0.6
30 μmol/mL0.5 ± 1.0
TLCK0.1 μmol/mL1.7 ± 2.1
1.0 μmol/mL1.1 ± 0.6
10 μmol/mL2.7 ± 1.7
100 μmol/mL3.5 ± 1.2
Amastatin0.1 μmol/mL1.5 ± 0.4
1.0 μmol/mL2.3 ± 0.6
10 μmol/mL3.9 ± 0.6
Leupeptin2.0 μmol /mL1.2 ± 0.7
20 μmol /mL2.0 ± 1.4
60 μmol /mL0.6 ± 0.5
200 μmol /mL4.7 ± 0.8a
Protamine0.1 μg/mL1.7 ± 1.3
1.0 μg/mL1.9 ± 1.4
10 μg/mL0.2 ± 2.1
100 μg/mL4.5 ± 0.5a
Anti-IgE10 μg/mL11 ± 2.7a
Calcium ionophone1.0 μg/mL18 ± 3.6a
Table 2 The effects of protease inhibitors on histamine release from human colon mast cells at 35 min incubation period
CompoundConcentrationNet histamine release (%)
ZIGPFM0.001 μmol/mL0.3 ± 0.3
0.01 μmol/mL1.0 ± 0.8
0.1 μmol/mL1.8 ± 1.3
1.0 μmol/mL1.9 ± 0.6
TPCK0.8 μmol/mL0.9 ± 2.1
8.0 μmol/mL1.8 ± 1.3
80 μmol/mL1.7 ± 3.6
TLCK1.0 μmol/mL0 ± 2.4
10 μmol/mL0.7 ± 1.9
100 μmol/mL0.7 ± 2.2
Amastatin0.1 μmol/mL1.0 ± 1.7
1.0 μmol/mL-1.9 ± 3.3
10 μmol/mL0 ± 3.6
Leupeptin2.0 μmol/mL1.0 ± 0.7
20 μmol/mL1.2 ± 0.7
60 μmol/mL0 ± 0.7
200 μmol/mL5.1 ± 0.5a
Protamine1.0 μg/mL1.2 ± 2.9
10 μg/mL1.0 ± 2.5
Anti-IgE10 μg/mL10.1 ± 2.5a
Calcium ionophone1.0 μg/mL21.8 ± 3.8a